SARS-COV-2 can induce an alteration of the autoimmune profile


https://doi.org/10.4081/wpph.2020.9246
Vol. 8 (2020)
Published: 30 June 2020
Abstract Views: 1419
PDF: 238
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Maria Cristina Sacchi
    csacchi@ospedale.al.it
    Settore di Autoimmunologia, Laboratorio Analisi, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.
  • Stefania Tamiazzo Settore di Autoimmunologia, Laboratorio Analisi, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.
  • Paolo Stobbione SSD Reumatologia, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.
  • Ernesto Cristiano Lauritano Unità di Medicina Intensiva, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.
  • Annalisa Roveta Infrastruttura Ricerca Formazione Innovazione, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.
  • Roberto Guaschino Settore di Autoimmunologia, Laboratorio Analisi, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.
  • Ramona Bonometti Unità di Medicina Intensiva, Azienda ospedaliera “SS.Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy.

Objective: The study evaluated the autoimmune profile of COVID-19 positive hospitalised patients. Methods: 40 hospitalised patients with a confirmed diagnosis of COVID-19 were given clinical chemistry and autoimmunity tests. Results: The 40 patients enrolled in our hospital had elevated levels of common inflammatory markers such as C-Reactive Protein (CRP), Lactate Dehydrogenase (LDH) and ferritin. Interleukin-6 (IL-6) concentration was also increased, confirming the key role of this interleukin during severe acute respiratory syndrome (SARS-CoV-2) infection. The most common autoimmunity tests were performed. A significant prevalence of anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccaromyces cerevisiae (ASCA IgA and IgG) was found. Patients showing a de novo autoantibody response were those with a worse disease prognosis. Conclusion: Our study shows that COVID-19 infection can trigger an autoimmune response and could induce the onset of autoimmune diseases. These data explain why drugs used to treat autoimmune diseases could also be useful in combating SARS-CoV-2 infection.


Sacchi, M. C., Tamiazzo, S., Stobbione, P., Lauritano, E. C., Roveta, A., Guaschino, R., & Bonometti, R. (2020). SARS-COV-2 can induce an alteration of the autoimmune profile. Working Paper of Public Health, 8(1). https://doi.org/10.4081/wpph.2020.9246

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)

1 2 > >>